Urmăriți
Orhan Tansel Korkmaz
Orhan Tansel Korkmaz
Eskisehir Osmangazi University , School of Medicine, Department of Physiology
Adresă de e-mail confirmată pe ogu.edu.tr
Titlu
Citat de
Citat de
Anul
7, 8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis
OT Korkmaz, N Aytan, I Carreras, JK Choi, NW Kowall, BG Jenkins, ...
Neuroscience letters 566, 286-291, 2014
902014
Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF …
OT Korkmaz, N Tunçel, M Tunçel, EM Öncü, V Şahintürk, M Çelik
Journal of molecular neuroscience 41, 278-287, 2010
592010
Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum
N Tunçel, OT Korkmaz, N Tekin, E Şener, F Akyüz, M Inal
Journal of Molecular Neuroscience 46, 51-57, 2012
502012
A simple and sensitive LC–ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates
D Yeniceli, E Şener, OT Korkmaz, D Doğrukol-Ak, N Tuncel
Talanta 84 (1), 19-26, 2011
392011
Modulation of corpus striatal neurochemistry by astrocytes and vasoactive intestinal peptide (VIP) in parkinsonian rats
İH Yelkenli, E Ulupinar, OT Korkmaz, E Şener, G Kuş, Z Filiz, N Tunçel
Journal of Molecular Neuroscience 59, 280-289, 2016
332016
Vasoactive intestinal peptide decreases β-amyloid accumulation and prevents brain atrophy in the 5xFAD mouse model of Alzheimer’s disease
OT Korkmaz, H Ay, N Aytan, I Carreras, NW Kowall, A Dedeoglu, N Tuncel
Journal of Molecular Neuroscience 68, 389-396, 2019
292019
Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats
OT Korkmaz, H Ay, E Ulupınar, N Tunçel
Journal of Molecular Neuroscience 48, 565-573, 2012
272012
Advantages of vasoactive intestinal peptide for the future treatment of Parkinson's disease
OT Korkmaz, N Tunçel
Current Pharmaceutical Design 24 (39), 4693-4701, 2018
252018
The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats
F Tore, OT Korkmaz, D Dogrukol-Ak, N Tunçel
Journal of molecular neuroscience 41, 288-293, 2010
132010
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI–LC–MS (ion trap)
E Sener, OT Korkmaz, D Yeniceli, D Dogrukol-Ak, M Tuncel, N Tuncel
Chromatographia 66, 31-36, 2007
132007
Determination of Ochratoxin-A in the brain microdialysates and plasma of awake, freely moving rats using ultra high performance liquid chromatography fluorescence detection method
EMÖ Kaya, OT Korkmaz, DY Uğur, E Şener, AN Tunçel, M Tunçel
Journal of Chromatography B 1125, 121700, 2019
112019
Can brain-derived neurotrophic factor (BDNF) mimetics be a way out for neurodegenerative diseases?
OT Korkmaz
Current Pharmaceutical Design 29 (4), 246-250, 2023
72023
The Effects of Carvacrol on Transient Receptor Potential (TRP) Channels in an Animal Model of Parkinson’s Disease
T Akan, Y Aydın, OT Korkmaz, E Ulupınar, F Saydam
Neurotoxicity Research 41 (6), 660-669, 2023
62023
Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP
OT Korkmaz, S Arkan, EM Öncü-Kaya, N Ateş, N Tunçel
Neuroscience Letters 765, 136268, 2021
42021
CRITICAL ROLE OF ASTROCYTES ON STRIATAL NEURO-CHEMISTRY IN VIP TREATED PARKINSONIAN RATS
N Tunçel, I Yelkenli, E Ulupinar, OT Korkmaz, E Sener, G Kus
JOURNAL OF MOLECULAR NEUROSCIENCE 51, S212-S212, 2013
12013
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI-LC-MS (ion trap)
E ŞENER, O KorkmaZ, D Yeniceli, D Do'grukol-Ak, M Tuncel, N Tuncel
CHROMATOGRAPHIA, 2007
12007
Increased Serotonin Levels and Unchanged Glutamate and GABA Levels in Thalamic Microdialysates Despite Reduced Cell Numbers in a Valproic Acid-Induced Autism Model
H Ay, E Horata, EM Öncü Kaya, OT Korkmaz
Neurochemical Research 50 (1), 1-11, 2025
2025
Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications for Cold Stress Adaptation
OT Korkmaz, F Saydam, B Dalkiran, İ Değirmenci, N Tunçel
Cell Biochemistry and Biophysics, 1-10, 2024
2024
Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma
F Yildiz, N Sahinoglu-Keskek, IT Yilmaz, İA Candan, OT Korkmaz
Journal of Current Ophthalmology 36 (2), 136-144, 2024
2024
Vasoactive Intestinal Peptide Differentially Modulates Neurogenesis in Experimental Parkinson's Disease Models
CC Meral, OT Korkmaz, N Tuncel
ACTA PHYSIOLOGICA 240, 62-62, 2023
2023
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20